Altre lingue Tango Therapeutics, Inc.

Azioni

TNGX

US87583X1090

Biotecnologia

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 15/05/2025			Variaz. 5gg	Var. 1 gen.
1,520 ^USD	+18,29%		+38,18%	-50,81%

12/05	Tango Therapeutics presenta una richiesta di registrazione mista fino a 400 milioni di dollari	RE
12/05	Tango Therapeutics, Inc. pubblica i risultati finanziari relativi al primo trimestre chiuso al 31 marzo 2025	CI

Altre lingue

Tango Therapeutics Files For Mixed Shelf Of Up To $400 Million	12/05
Tango Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	12/05
Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights	12/05
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025	01/05
Barbara Weber, M.D., Elected to ITM Supervisory Board	10/04
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025	25/03
Tango Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	27/02
Tango Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	27/02
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights	27/02
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences	20/02
Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference	30/01
Tango Therapeutics, Inc.(NasdaqGM:TNGX) dropped from S&P Biotechnology Select Industry Index	23/12
Tango Therapeutics : Corporate Presentation	05/12
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/12
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference	27/11
Health Care Up Amid Mixed Earnings -- Health Care Roundup	06/11
Sector Update: Health Care Stocks Mixed Late Afternoon	06/11
Top Midday Decliners	06/11
Wall Street Cheers Trump Election Win as US Equity Futures Rise Pre-Bell	06/11
Top Premarket Decliners	06/11
Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	06/11
Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q3 Revenue $11.6M	06/11
Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q3 Loss $-0.27	06/11
Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q3 Loss $-0.27 Per Share	06/11
Tango Therapeutics : Reports Third Quarter 2024 Financial Results and Provides Business Highlights Form 8 K	06/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tango Therapeutics, Inc.

Azioni

TNGX

US87583X1090

Biotecnologia

Altre lingue

Filtri